The WHO on Tuesday continued to express confidence in the H1N1 (swine flu) vaccine as few mild adverse effects have been reported by patients participating in China’s vaccine campaign, the Associated Press reports. Out of the 39,000 people in China who received the H1N1 vaccine, four reported experiencing side effects such as muscle cramps and headache, according to WHO spokesman Gregory Hartl (Higgins, 10/6).
The number of H1N1 (swine flu) cases reported in WHO regions worldwide has grown by at least 24,000 in two weeks to cross the 340,000 mark since the virus was first detected in mid-April, the CDC reported Monday, according to Agence France-Presse.
U.N. officials on Sunday said that the H1N1 (swine flu) virus had arrived in poorer countries, highlighting a growing need for financial assistance and H1N1 vaccines for such regions, SAPA/News24.com reports.
Recent Releases: Measuring Maternal Death; Improving Health Systems; Goosby Remarks; World Health Summit; Early Nutrition Programs; ART Delivery Model; HIV/AIDS Research; Cash Transfers As A Standard For Aid; G20, U.N. Neglect Global Health
Researchers Tackle How To Capture ‘An Accurate Picture’ Of Maternal Death In order to meet the Millennium Development Goal to reduce maternal deaths, “countries need an accurate picture of the causes and levels of maternal deaths,” write the authors of a WHO Bulletin editorial that describes the recent efforts by…
U.S. health officials announced Thursday the first batches of the H1N1 (swine flu) vaccine the government ordered will begin arriving in designated locations across the country on Tuesday and may be administered in the first patients by the end of next week, Reuters reports.
The first H1N1 (swine flu) vaccine shots available in the U.S. were shipped ahead of schedule after the pharmaceutical company Sanofi-Aventis finished production nearly two weeks early, the chief executive of the company said Tuesday, the New York Times reports.
Additional countries are expected to soon announce they will follow in the footsteps of nine developed countries who recently said they would donate H1N1 (swine flu) vaccine supplies to poorer nations, David Nabarro, of the U.N. said Friday, Reuters reports.
International drug makers are expected to produce three billion doses of the H1N1 (swine flu) vaccine, “enough for just under half the world’s population,” a WHO official said Thursday, Canwest News Service/Ottawa Citizen reports. “The agency was hoping pharmaceutical companies would be able to make about five billion doses a year, but data collected over the summer led to the revised estimate,” the news service writes.
During the WHO Asia-Pacific regional meeting Monday, WHO Director-General Margaret Chan discussed the organization’s efforts to ensure that poor nations have access to H1N1 vaccines, VOA News reports (Bayron, 9/21). ABC Radio Australia reports Chan is seeking “three billion doses of swine flu vaccine to be made available worldwide, especially in developing countries where it still poses a serious risk” (9/22).
The U.N. this week will request that wealthy nations and development banks donate $1.48 billion to the help developing countries fight H1N1 (swine flu), Bloomberg reports.